Rinvoq ER 45 MG tablet UU 28S
Ended Awarded
- Contract number
- SPE2DB25FHH62
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $66,032
Award facts
- Contract value 100% obligated
- $66,032.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $66,032.21 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 6, 2025, for the supply of RINVOQ ER 45 mg tablets (28-count unit of use packaging). This non-set-aside contract is classified as a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The delivery order is scheduled for completion by June 9, 2025, with performance at the company's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its extensive relationship with the Defense Logistics Agency's Medical Supply Chain. The company supplies a comprehensive range of pharmaceutical products to support military and veteran healthcare systems, demonstrating significant capability in fulfilling federal medical supply requirements through competitive procurement processes. This particular delivery order for the rheumatoid arthritis treatment RINVOQ represents one of numerous pharmaceutical deliveries the company fulfills under its prime IDC vehicle, which enables flexible sourcing of medications and medical supplies across multiple therapeutic domains for defense health operations.
Quick answers
Who was awarded contract SPE2DB25FHH62?
SPE2DB25FHH62 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 6, 2025.
How much is contract SPE2DB25FHH62 worth?
The government has obligated $66,032 on SPE2DB25FHH62.
Is contract SPE2DB25FHH62 an order under another contract?
Yes. SPE2DB25FHH62 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FHH62 competed?
The extent of competition for SPE2DB25FHH62 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award